Jeffrey A Yoder Selected Research

Drug Combinations

10/2022

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Yoder Research Topics

Disease

4	Infections 01/2017 - 11/2010
3	Neoplasms (Cancer) 10/2022 - 01/2018
2	Leukemia 10/2022 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2016
2	Virus Diseases (Viral Diseases) 01/2017 - 01/2013
2	Sepsis (Septicemia) 03/2013 - 08/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2022
1	Down Syndrome (Down's Syndrome) 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Nervous System Diseases (Neurological Disorders) 09/2019
1	Central Nervous System Diseases (CNS Diseases) 09/2019
1	Autoimmune Diseases of the Nervous System 09/2019
1	Bites and Stings (Sting) 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2013
1	Inflammation (Inflammations) 03/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2013
1	Acute Lung Injury 03/2013
1	Pneumonia (Pneumonitis) 08/2011
1	Dog Diseases (Disease, Canine) 08/2011
1	Pseudomonas Infections 11/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2010
1	Cystic Fibrosis (Mucoviscidosis) 11/2010
1	Carcinogenesis 02/2010
1	Autoimmune Diseases (Autoimmune Disease) 04/2009
1	Large Granular Lymphocytic Leukemia 12/2008
1	Congenital Abnormalities (Deformity) 08/2006
1	Pancreas Divisum 08/2006

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2009
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2010
2	UbiquitinIBA 01/2018 - 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2022
1	temsirolimus FDA Link 10/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2022
1	Lymphocyte Specific Protein Tyrosine Kinase p56(lck) (p56 lck)IBA 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Dasatinib (BMS 354825)FDA Link 10/2022
1	Drug CombinationsIBA 10/2022
1	Versicans (Versican)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	AutoantibodiesIBA 09/2019
1	Surface Antigens (Surface Antigen)IBA 09/2019
1	AntibodiesIBA 09/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	InterferonsIBA 01/2017
1	MethyltransferasesIBA 01/2017
1	NucleotidesIBA 01/2017
1	Biological ProductsIBA 01/2016
1	Protein Kinase CIBA 03/2013
1	MucinsIBA 03/2013
1	CytokinesIBA 03/2013
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 03/2013
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2013
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2010
1	Virulence Factors (Pathogenicity Factors)IBA 11/2010
1	Farnesyltranstransferase (Farnesyltransferase)IBA 12/2008
1	RetinoidsIBA 08/2006

Therapy/Procedure

3	Therapeutics 10/2022 - 08/2011
1	Transplantation 03/2014